The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Morning Seminar

MS2-9

Recent advances in the treatment of myelodysplastic syndromes (MDS) : The roles of transfusion and iron chelation therapy

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Hiroshi Kawabata (Department of Hematology and Immunology, Kanazawa Medical University)

Sponsor: Novartis Pharma K.K.

[MS2-9] Recent advances in the treatment of myelodysplastic syndromes (MDS) : The roles of transfusion and iron chelation therapy

Akihiko Gotoh (Department of Hematology, Juntendo University School of Medicine)